DMAA — Drugs Made In America Acquisition Corp. Ordinary Shares stock price, charts and financials

QT41Drugs Made In America Acquisition Corp. Ordinary Shares

Drugs Made In America Acquisition Corp. Ordinary Shares (NASDAQ: DMAA) is a Financial Services company in the Shell Companies industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
10.70
-0.00-0.05%
OverviewShort InterestFilings
DMAAQT41Drugs Made In America Acquisition Corp. Ordinary Shares·NASDAQ
10.70-0.05%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 20, 20268-KCurrent report
Jul 20, 2026425Prospectus / business-combination communication
Jun 26, 2026SC 13GBeneficial ownership statement (passive)
May 14, 2026SC 13GBeneficial ownership statement (passive)
May 14, 202610-QQuarterly report
May 05, 2026425Prospectus / business-combination communication
May 05, 20268-KCurrent report
May 01, 20268-KCurrent report
Apr 28, 20268-KCurrent report
Apr 16, 2026DEFR14ADEFR14A
Apr 15, 202610-KAnnual report
Apr 14, 2026DEF 14ADefinitive proxy statement
Apr 08, 20268-KCurrent report
Apr 01, 2026NT 10-KNT 10-K
Mar 27, 2026PRE 14APreliminary proxy statement
Mar 27, 20268-KCurrent report
Mar 06, 20268-KCurrent report
Mar 06, 20268-KCurrent report
Nov 18, 20258-KCurrent report
Nov 18, 202510-QQuarterly report
Nov 17, 2025NT 10-QNT 10-Q
Nov 12, 2025SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2025SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 202510-QQuarterly report
May 20, 202510-QQuarterly report
#1 / 25 of 71
Page
▼
/ 3